{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:09:27Z","timestamp":1777950567111,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.7759\/cureus.108214","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:41:31Z","timestamp":1777880491000},"source":"Crossref","is-referenced-by-count":0,"title":["Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Onset in Pregnancy: A Case Report"],"prefix":"10.7759","author":[{"given":"Adri\u00e1n","family":"Infante Valenzuela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo  A","family":"Salda\u00f1a Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adlen S","family":"Mart\u00ednez Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego A","family":"Garc\u00eda Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irma A","family":"Villarreal Ondarza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Flores Alfaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Saldivar D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz E","family":"Ch\u00e1vez Lu\u00e9vanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"G\u00f3ngora-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl M","year":"2019","unstructured":"Reindl M, Waters P. Myelin oligodendrocyte glycoprotein antibodies in neurological disease. Nat Rev Neurol. 2019, 15:89-102. 10.1038\/s41582-018-0112-x","journal-title":"Nat Rev Neurol"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier R","year":"2021","unstructured":"Marignier R, Hacohen Y, Cobo-Calvo \u00c1, et al.. Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 2021, 20:762-72.","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk M","year":"2017","unstructured":"Jurynczyk M, Messina S, Woodhall MR, et al.. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 2017, 140:3128-38. 10.1093\/brain\/awx276","journal-title":"Brain"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study","volume":"90","author":"Cobo-Calvo A","year":"2018","unstructured":"Cobo-Calvo A, Ruiz A, Maillart E, et al.. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: the MOGADOR study. Neurology. 2018, 90:e1858-69. 10.1212\/WNL.0000000000005560","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius S","year":"2018","unstructured":"Jarius S, Paul F, Aktas O, et al.. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing. J Neuroinflammation. 2018, 15:134. 10.1186\/s12974-018-1144-2","journal-title":"J Neuroinflammation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000766","article-title":"Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis","volume":"33","author":"Chen JJ","year":"2020","unstructured":"Chen JJ, Bhatti MT. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Curr Opin Neurol. 2020, 33:47-54. 10.1097\/WCO.0000000000000766","journal-title":"Curr Opin Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan S","year":"2018","unstructured":"Ramanathan S, Mohammad S, Tantsis E, et al.. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018, 89:127-37. 10.1136\/jnnp-2017-316880","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.1067277","article-title":"Serial analyses of clinical spectra and outcomes in Chinese women with pregnancy-induced optic neuritis","volume":"9","author":"Bai W","year":"2022","unstructured":"Bai W, Sun M, Song H, et al.. Serial analyses of clinical spectra and outcomes in Chinese women with pregnancy-induced optic neuritis. Front Med (Lausanne). 2022, 9:1067277. 10.3389\/fmed.2022.1067277","journal-title":"Front Med (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1048502","article-title":"Pregnancy and antibody-mediated CNS disorders: what do we know and what should we know?","volume":"13","author":"Cortese R","year":"2022","unstructured":"Cortese R, Mariotto S, Mancinelli CR, Tortorella C. Pregnancy and antibody-mediated CNS disorders: what do we know and what should we know?. Front Neurol. 2022, 13:1048502. 10.3389\/fneur.2022.1048502","journal-title":"Front Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria","volume":"22","author":"Banwell B","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, et al.. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD panel proposed criteria. Lancet Neurol. 2023, 22:268-82. 10.1016\/S1474-4422(22)00431-8","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2023.104760","article-title":"A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD)","volume":"75","author":"Leite MI","year":"2023","unstructured":"Leite MI, Panahloo Z, Harrison N, Palace J. A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD). Mult Scler Relat Disord. 2023, 75:104760. 10.1016\/j.msard.2023.104760","journal-title":"Mult Scler Relat Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209706","article-title":"Pearls & oy-sters: optic neuritis as first demyelinating event during pregnancy in 2 young Hispanic women: MS vs MOGAD","volume":"103","author":"Karalius M","year":"2024","unstructured":"Karalius M, Mohan S, Paredes D, Rasool N, Bove R. Pearls & oy-sters: optic neuritis as first demyelinating event during pregnancy in 2 young Hispanic women: MS vs MOGAD. Neurology. 2024, 103:e209706. 10.1212\/WNL.0000000000209706","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1211776","article-title":"Comparing clinical and imaging features of patients with MOG antibody-positivity and with and without oligoclonal bands","volume":"14","author":"Tomizawa Y","year":"2023","unstructured":"Tomizawa Y, Hoshino Y, Kamo R, Cossu D, Yokoyama K, Hattori N. Comparing clinical and imaging features of patients with MOG antibody-positivity and with and without oligoclonal bands. Front Immunol. 2023, 14:1211776. 10.3389\/fimmu.2023.1211776","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/480019-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-onset-in-pregnancy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:41:32Z","timestamp":1777880492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/480019-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease-onset-in-pregnancy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.108214","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,4]]}}}